Journal List > Korean J Gastroenterol > v.55(6) > 1006680

Park, Chung, Cho, Lee, Kim, Choi, Rew, and Chung: Hypertriglyceridemia-Induced Pancreatitis Treated with Insulin in a Nondiabetic Patient

Abstract

Heparin and/or insulin stimulate lipoprotein lipase and are known to decrease serum triglyceride level. However, their efficacy in hypertriglyceridemia-induced acute pancreatitis in nondiabetic patients is not well documented. We report a case of hypertriglyceridemia-induced pancreatitis in 43-year-old nondiabetic woman in whom treatment with insulin was accompanied by reduction in serum triglyceride level and the resolution of pancreatitis. She presented to the emergency department with abdominal pain and biochemical evidence of acute pancreatitis. Her medical history was unremarkable. There was no history of alcohol consumption, and biliary imaging was not remarkable. Subsequent laboratory investigation revealed marked hypertriglyceridemia (1,951 mg/dL), impaired fasting glucose, and normal HbAlc level. The Ranson's score and APATCH II score were 1 and 4. Abdominal CT showed diffuse enlargement of pancreas, peripancreatic fat infiltration, and multiple fluid collections around the pancreas. We treated the patient with the infusion of 5% dextrose and 1.5 unit/hr regular insulin to reduce serum triglyceride level. The level of serum triglyceride was decreased to 305 mg/dL on day 5. During the remainder of hospitalization, her clinical symptoms and laboratory values gradually improved.

REFERENCES

1. Fortson MR, Freedman SN, Webster PD 3rd. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol. 1995; 90:2134–2139.
2. Toskes PP. Hyperlipidemic pancreatitis. Gastroenterol Clin North Am. 1990; 19:783–791.
crossref
3. Tsuang W, Navaneethan U, Ruiz L, Palascak JB, Gelrud A. Hypertriglyceridemic pancreatitis: presentation and management. Am J Gastroenterol. 2009; 104:984–991.
crossref
4. Chuang TY, Chao CL, Lin BJ, Lu SC. Gestational hyperlipidemic pancreatitis caused by type III hyperlipoproteinemia with apolipoprotein E2/E2 homozygote. Pancreas. 2009; 38:716–717.
crossref
5. Muller DP, Pavlou C, Whitelaw AG, McLintock D. The effect of pregnancy and two different contraceptive pills on serum lipids and lipoproteins in a woman with a type III hy-perlipoproteinaemia pattern. Br J Obstet Gynaecol. 1978; 85:127–133.
crossref
6. Yoon YK, Ji JH, Mun BS. Hypertriglyceridemia-induced pancreatitis. Korean J Gastroenterol. 2008; 51:309–313.
7. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28:412–419.
8. Radikova Z, Koska J, Huckova M, et al. Insulin sensitivity indices: a proposal of cutoff points for simple identification of insulin-resistant subjects. Exp Clin Endocrinol Diabetes. 2006; 114:249–256.
crossref
9. Yadav D, Pitchumoni CS. Issues in hyperlipidemic pancreatitis. J Clin Gastroenterol. 2003; 36:54–62.
crossref
10. Kim YJ, Kim HJ, Kim HC, Kim SJ, Park SH. A case of acute hyperlipidemic pancreatitis in a patient suspected of familial combined hyperlipidemia. Korean J Med. 2005; 69:197–201.
11. Kimura T, Toung JK, Margolis S, Permutt S, Cameron JL. Respiratory failure in acute pancreatitis: a possible role for triglycerides. Ann Surg. 1979; 189:509–514.
12. Warshaw AL, Lesser PB, Rie M, Cullen DJ. The pathogenesis of pulmonary edema in acute pancreatitis. Ann Surg. 1975; 182:505–510.
crossref
13. Hofbauer B, Friess H, Weber A, et al. Hyperlipaemia in-tensifies the course of acute oedematous and acute necrotising pancreatitis in the rat. Gut. 1996; 38:753–758.
crossref
14. Brian Haig TH. Experimental pancreatitis intensified by a high fat diet. Surg Gynecol Obstet. 1970; 131:914–918.
15. Szczepiorkowski ZM, Bandarenko N, Kim HC, et al. Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Appli-cations Committee of the American Society for Apheresis. J Clin Apher. 2007; 22:106–175.
16. Eckel RH. Lipoprotein lipase. A multifunctional enzyme rele-vant to common metabolic diseases. N Engl J Med. 1989; 320:1060–1068.
17. Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res. 1996; 37:693–707.
crossref
18. Ong JM, Kirchgessner TG, Schotz MC, Kern PA. Insulin increases the synthetic rate and messenger RNA level of lipoprotein lipase in isolated rat adipocytes. J Biol Chem. 1988; 263:12933–12938.
crossref
19. Korn ED. Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart. J Biol Chem. 1955; 215:1–14.
20. Berger Z, Quera R, Poniachik J, Oksenberg D, Guerrero J. Heparin and insulin treatment of acute pancreatitis caused by hypertriglyceridemia. Experience of 5 cases. Rev Med Chil. 2001; 129:1373–1378.
21. Monga A, Arora A, Makkar RP, Gupta AK. Hypertriglycer-idemia-induced acute pancreatitis–treatment with heparin and insulin. Indian J Gastroenterol. 2003; 22:102–103.
22. Mikhail N, Trivedi K, Page C, Wali S, Cope D. Treatment of severe hypertriglyceridemia in nondiabetic patients with insulin. Am J Emerg Med. 2005; 23:415–417.
crossref
23. Jain P, Rai RR, Udawat H, Nijhawan S, Mathur A. Insulin and heparin in treatment of hypertriglyceridemia-induced pancreatitis. World J Gastroenterol. 2007; 13:2642–2643.
crossref

Fig. 1.
Lipoprotein electrophoresis. It showed type III hyperlipoproteinemia pattern during acute phase.
kjg-55-399f1.tif
Fig. 2.
Abdominal computed tomography (CT). (A) Initial abdominal CT showed diffuse enlargement of pancreas and peripancreatic fat infiltration. (B) It showed multiple fluid collections in the peripancreatic, perisplenic, and pararenal space.
kjg-55-399f2.tif
TOOLS
Similar articles